Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.
暂无分享,去创建一个
J. Niloff | R. Berkowitz | J. Garber | D. Cramer | W. Welch | M. Muto | D. Schrag | K. Lu | Ross S. Berkowitz | William R. Welch | Judy Garber | Karen H. Lu | Daniel W. Cramer | Deborah Schrag | J. Garber | Daniel W. Cramer
[1] O. Olopade,et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.
[2] R. L. Baldwin,et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. , 1999, American journal of obstetrics and gynecology.
[3] J. Niloff,et al. A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer. , 1999, Obstetrics and gynecology.
[4] B. Modan,et al. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors. , 1998, Journal of the National Cancer Institute.
[5] R. Berkowitz,et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. , 1998, Journal of the National Cancer Institute.
[6] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[7] J. Ranstam,et al. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] D. Berry,et al. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. , 1998, American journal of human genetics.
[9] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[10] A. Godwin,et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. , 1996, Journal of the National Cancer Institute.
[11] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[12] R. Berkowitz,et al. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center. , 1993, Gynecologic oncology.
[13] M. Piver,et al. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the gilda radner familial ovarian cancer registry , 1993, Cancer.
[14] Chen Kt,et al. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. , 1985 .
[15] J. Tobacman,et al. INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES , 1982, The Lancet.